SP
Starpharma Holdings Limited
SPHRF · OTC
$0.47 +0.00% (+$0.00)
Market Cap $274.7M
P/E Ratio -
Div. Yield -
ROE 38.53%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/B 19.97x
P/S 22.83x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 26.62%
Rev. growth 40.45%
FCF growth N/A
Profitability
20 /100
Weak Net margin 61.95%
Op. margin 159.60%
FCF margin 29.02%
Quality
8 /100
Poor ROE 38.53%
ROA 39.25%
Asset turnover 0.63x
Debt
100 /100
Low Current ratio 3.40x
Debt/Equity 0.05x
Net debt/EBITDA N/A
Stability
43 /100
Moderate Rev. volatility 95.51%
EPS volatility 35.36%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SPHRF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Cheryl Maley
Employees
50
Headquarters
Abbotsford
Prihajajoči dogodki
02 MAR.
Earnings
Upcoming earnings report